Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide  

https://www.globenewswire.com/news-release/2017/10/12/1144885/0/en/Zealand-has-initiated-a-clinical-trial-to-evaluate-the-potential-for-less-than-once-daily-dosing-with-its-long-acting-GLP-2-analog-glepaglutide.html

press release